Virpax Pharmaceuticals, Inc.
OTC: VRPX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jatinder Dhaliwal
- Employees
- 2
- Headquarters
- Berwyn, United States
- IPO year
- 2021
- Market cap
- $13.8K
- Website
- https://www.virpaxpharma.com
Loading VRPX…
Loading profile data…Frequently asked questions about VRPX
What does Virpax Pharmaceuticals, Inc. (VRPX) do?
Virpax Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical enterprise, dedicated to pioneering diverse drug-delivery systems and novel drug-releasing technologies. Its core focus lies in developing advanced, non-opioid and non-addictive solutions for pain management, alongside therapies targeting central nervous system disorders...
Where does VRPX trade?
Virpax Pharmaceuticals, Inc. (VRPX) trades on the Other OTC.
What sector is VRPX in?
Virpax Pharmaceuticals, Inc. (VRPX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Virpax Pharmaceuticals, Inc.?
Jatinder Dhaliwal is the chief executive officer of Virpax Pharmaceuticals, Inc. (VRPX).
Where is Virpax Pharmaceuticals, Inc. headquartered?
Virpax Pharmaceuticals, Inc. is headquartered in United States.
Does VRPX pay a dividend?
Virpax Pharmaceuticals, Inc. (VRPX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did VRPX go public?
Virpax Pharmaceuticals, Inc. (VRPX) completed its initial public offering in 2021.